IDIBELL on the media
Sara Calvo receives the award for the best health research article for doctoral students at the 15th ICS Conference
Maria Molina, scientific director of IDIBELL, moderated the round table on the research career at the ICS.
Scientists identify biomarkers in semen samples that could help reduce overdiagnosis in prostate cancer screening
IDIBELL researchers have led the discovery of biomarkers that could improve the non-invasive detection of clinically relevant prostate cancer cases.
A study published in JAMA shows the good results of a new extracorporeal blood purification membrane
The results of the SIRAKI02 study show that the use of a new extracorporeal blood purification membrane reduces acute kidney failure after complex cardiac surgery.
Promising preclinical results against lung cancer with innovative strategies to combat resistance
Two studies reveal new therapeutic approaches for lung cancer patients with BRAFV600E and KRASG12C mutations. The advanced preclinical models generated by IDIBELL and ICO professionals have been essential for this research.
A study conducted in Bellvitge reveals the diversity in sleep apnea in women and proposes a review in diagnostic approaches
This new study, based on 1,886 women with sleep apnea, reveals a heterogeneous presentation of the pathology in women similar to that of men, contrary to previous literature that often associated women with a predominantly atypical presentation.
IDIBELL participates in the European project UMBRELLA
UMBRELLA addresses the stroke care process from diagnosis, prevention, episode care and rehabilitation.
IDIBELL gains presence in the list of scientists with the highest impact in the world: four more than last year
The Stanford University Top 2% of Scientists, which includes the most impactful scientists of the world, includes this year 34 IDIBELL researchers, of which three reaffirm their position among the top 10 in Spain and four have first entered.
IDIBELL receives funding from the US National Institutes of Health to advance neural regeneration
The Northwestern University (Chicago), IDIBELL and IBEC were awarded a NIH project that will help develop new treatments for spinal cord injuries and other neurodegenerative pathologies.
